Overview
Infantile non-syndromic cataract (Orphanet code 217052) is an obsolete clinical entity that was previously used to describe congenital or early-onset lens opacities (cataracts) occurring in infants without associated systemic features (i.e., not part of a broader genetic syndrome). This condition has been reclassified and merged into broader categories of isolated or non-syndromic congenital cataracts within the Orphanet classification system. Non-syndromic congenital cataracts affect the lens of the eye, leading to partial or complete opacification that can impair vision development during a critical period of visual maturation. If left untreated, significant cataracts in infancy can result in amblyopia (lazy eye) and permanent visual impairment. Congenital cataracts can present in various morphological forms, including nuclear, lamellar, cortical, posterior polar, or total cataracts. The condition may be unilateral or bilateral. Isolated (non-syndromic) congenital cataracts can be inherited in autosomal dominant, autosomal recessive, or X-linked patterns, depending on the specific genetic cause. Numerous genes have been implicated, including those encoding crystallins (e.g., CRYAA, CRYBB2, CRYGD), connexins (e.g., GJA3, GJA8), and other lens-related proteins. Treatment typically involves surgical removal of the opacified lens, often followed by optical correction with intraocular lens implantation, contact lenses, or glasses, along with amblyopia therapy. Early intervention is critical to optimize visual outcomes. Because this Orphanet entry is now obsolete, patients and clinicians should refer to the current classification of non-syndromic congenital cataracts for up-to-date information.
Variable
Can be inherited in different ways depending on the underlying gene
Infantile
Begins in infancy, roughly 1 month to 2 years old
FDA & Trial Timeline
1 eventHEMANGEOL: FDA approved
Treatment of proliferating infantile hemangioma requiring systemic therapy.
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for OBSOLETE: Infantile non-syndromic cataract.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for OBSOLETE: Infantile non-syndromic cataract at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for OBSOLETE: Infantile non-syndromic cataract.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to OBSOLETE: Infantile non-syndromic cataract.
Community
No community posts yet. Be the first to share your experience with OBSOLETE: Infantile non-syndromic cataract.
Start the conversation →Latest news about OBSOLETE: Infantile non-syndromic cataract
No recent news articles for OBSOLETE: Infantile non-syndromic cataract.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about OBSOLETE: Infantile non-syndromic cataract
What is OBSOLETE: Infantile non-syndromic cataract?
Infantile non-syndromic cataract (Orphanet code 217052) is an obsolete clinical entity that was previously used to describe congenital or early-onset lens opacities (cataracts) occurring in infants without associated systemic features (i.e., not part of a broader genetic syndrome). This condition has been reclassified and merged into broader categories of isolated or non-syndromic congenital cataracts within the Orphanet classification system. Non-syndromic congenital cataracts affect the lens of the eye, leading to partial or complete opacification that can impair vision development during a
At what age does OBSOLETE: Infantile non-syndromic cataract typically begin?
Typical onset of OBSOLETE: Infantile non-syndromic cataract is infantile. Age of onset can vary across affected individuals.